# Adyn

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/adyn

- Industry: Biotechnology
- Headquarters: US
- Website: www.adyn.com
- Total disclosed funding: $2.5M
- Latest round: Seed (Apr 19, 2021)
- Investors on record: 8

## About

Adyn is a company focused on delivering personalized birth control solutions, offering innovative services that analyze genetic backgrounds and hormone levels to provide tailored contraceptive recommendations.Founded in 2019 in the US, Adyn specializes in personalized reproductive health solutions. The company was founded by Elizabeth Ruzzo, who has a history in health technology. Adyn secured USD 2.5 mn in Seed funding on April 19, 2021, co-led by Lux Capital and M13, with contributions from several other investors.Adyn specializes in personalized birth control solutions through its flagship product, The Birth Control Test. This innovative service utilizes a precision medicine approach to analyze an individual's genetic background and hormone levels to assess the risk of side effects associated with various birth control methods. By taking a simple at-home test, users can discover their unique biology and receive tailored recommendations among nearly 200 available contraceptive options. The primary end users include individuals seeking effective birth control solutions while minimizing adverse side effects, addressing a significant gap in the market where many users experience trial and error with traditional contraceptive methods. The company targets markets across the United States, appealing to a diverse clientele that includes women of reproductive age who are exploring safe and effective birth control alternatives.Adyn's revenue model is structured around direct-to-consumer transactions, primarily through the sale of The Birth Control Test. Customers purchase the test, which serves as the entry point for personalized contraceptive recommendations. The transaction process involves a one-time purchase for the test, with options for gifting additional tests, thus expanding its appeal. As part of its pricing structure, Adyn offers promotional discounts, such as seasonal offers. The company may also engage users through subscription-based models for ongoing hormone mapping and follow-up consultations, enhancing customer retention and continuous engagement. Overall, Adyn’s revenue streams are driven by individual consumers seeking tailored reproductive health solutions, bolstered by strategic marketing initiatives to increase awareness and accessibility.In April 2021, Adyn raised USD 2.5 mn in Seed funding to advance its personalized birth control initiatives. The funds will be allocated specifically for expanding the development and marketing of its personalized birth control solutions. The company plans to introduce new products that enhance user experience and efficacy in contraceptive choices, although specific release dates are yet to be announced. Additionally, Adyn aims to extend its reach into new markets beyond the current U.S. focus, with particular attention towards expanding internationally by 2023.

## Funding rounds

- Seed, Apr 19, 2021, $2.5M — Madrona Venture Group, Lux Capital, Y Combinator, M13, Civilization Ventures, Ascend, Westbound
- Seed, Jul 1, 2020 — Pioneer Fund

## Investors

- Pioneer Fund (https://capitalatlas.ai/funds/pioneer-fund) — Seed
- Madrona Venture Group (https://capitalatlas.ai/funds/madrona-venture-group) — Seed
- Lux Capital (https://capitalatlas.ai/funds/lux-capital) — Seed
- Y Combinator (https://capitalatlas.ai/funds/y-combinator) — Seed
- M13 (https://capitalatlas.ai/funds/m13) — Seed
- Civilization Ventures (https://capitalatlas.ai/funds/civilization-ventures) — Seed
- Ascend — Seed
- Westbound (https://capitalatlas.ai/funds/westbound) — Seed